Regen BioPharma, Inc. Submits IND Application to FDA on tCellVax, a Checkpoint Inhibitor for Cancer Therapy. New approach uses siRNA to silence NR2F6 activity in human immune cells.

Leave a Reply

Your email address will not be published.